Kambhampati S, Shumilov E, Saumoy M, Herrera AF, et al. Cost-effectiveness of polatuzumab vedotin in combination with chemoimmunotherapy (pola-R-CHP) in previously untreated diffuse large B-cell lymphoma in Germany. Br J Haematol 2023 May 15. doi: 10.1111/bjh.18869.
PMID: 37188351